Month: February 2021

MONTRÉAL, Feb. 16, 2021 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR) (FRANKFURT: 58V), is very pleased to announce the results of its Induced Polarization geophysical survey that was completed over priority portions of the Wabash copper-silver property in December 2020 and completed in January 2021.The survey covered an area 3.5km long and included a total of 30-line kilometers covering the Cloutier-Lapointe areas which had been the targets of the trenching program in the fall of 2020. The survey data was analyzed in conjunction with the recently published soil geochemistry and the geological information collected in 2020. Based on these results, six (6) priority targets were identified which will be further evaluated this summer. Four (4) of these targets had no surface work at all...

MONTRÉAL, 16 févr. 2021 (GLOBE NEWSWIRE) — Exploration Kintavar Inc. (la « Société » ou « Kintavar ») (TSX-V: KTR) (FRANCFORT: 58V), est très heureuse d’annoncer les résultats de son levé géophysique de polarisation provoquée (PP) qui a été réalisé sur les secteurs prioritaires de la propriété de cuivre-argent, Wabash, qui a débuté en décembre 2020 et a été complété en janvier 2021.Le levé s’étend sur près de 3,5 km, nord-sud, pour un total de 30 kilomètres linéaires de levés au sol dans les secteurs Cloutier-Lapointe qui ont fait l’objet de tranchées à l’automne 2020. Les données du levé ont été analysées en parallèle avec les anomalies de sols, qui ont déjà été publiées, et les informations géologiques recueillies en 2020. Ces résultats ont permis d’identifier six (6) secteurs cibles prioritaires qui seront investigués cet...

HOUSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the pricing of its previously announced public offering for the offering of 1,710,600 shares of common stock at a price to the public of $7.60 per share, for aggregate gross proceeds to the Company of approximately $13.0 million, before deducting the fees and estimated offering expenses payable by the Company. The offering is expected to close on or about February 18, 2021, subject to customary closing conditions.Roth Capital Partners acted as the sole placement agent for the offering.Bio-Path currently intends to use the net proceeds from the offering for working capital...

Philadelphia, PA, Feb. 16, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and retail marketing technology, is partnering with EOS Linx to provide solar-powered security solutions at its deployments in the U.S. and Territories with the installation of VSBLTY’s AI-driven Vector™ software. The state-of-the-art proprietary software, which includes facial detection of persons of interest, will sound a loud audio warning to any intruders, identify known subjects and send immediate alerts to company security and local law enforcement.VSBLTY has a strong presence in retail and other venues, including “Smart City” type deployments. The firm’s industry-leading VisionCaptor™ and DataCaptor™ software combine motion graphics and interactive brand messaging...

ANN ARBOR, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has filed a patent application protecting its most advanced knock-in knock-out gene editing technologies for the creation of nearly pure spider silk.Entitled “Modification of Heavy Chain Fibrion in Bombyx Mori“, this patent covering the core technologies the Company has developed for the mass production of nearly pure spider silk fibers. Specifically, the Company has leveraged the application of knock-in knock-out technology to create the most genetically advanced and purest spider silk fibers in the Company’s history. The Company has also filed a corresponding patent application...

ALPHARETTA, Ga., Feb. 16, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that David M. Brown, M.D. delivered a presentation entitled, “Axitinib: A Novel TKI Delivered by Suprachoroidal Injection for AMD” at the virtual Angiogenesis, Exudation, and Degeneration 2021 program hosted by the University of Miami Health System Bascom Palmer Eye Institute on February 12 & 13, 2021.Dr. Brown’s presentation highlighted several of the key attributes of axitinib and Clearside’s suprachoroidal delivery of the agent, including the ease of administration as demonstrated in a video of a clinical trial patient undergoing the office-based suprachoroidal...

DENVER, Feb. 16, 2021 (GLOBE NEWSWIRE) — NewAge, Inc. (Nasdaq: NBEV), the Colorado-based social selling and distribution company with a global network of independent brand partners and distributors today announced that it has entered into a definitive agreement with investors to purchase 14.6 million shares of common stock in a private placement priced at-the-market under Nasdaq rules. The purchase price for the shares of common stock is $3.96.The gross proceeds from the private placement are expected to be $58 million before deducting placement agent fees and other estimated offering expenses. As part of the private placement, investors will receive warrants to purchase up to 7.3 million additional shares at $5.00 per share, a 28% premium to the most recent closing price.The private placement is expected to close on or about February...